Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG), Boston ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

In this article, we are going to take a look at where Boston Scientific ... database management. “We’re going to use, essentially, the robots to be a member of the healthcare team in the ...

RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer ...

Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunitiesDr. Sabine ...

Boston Scientific. "We have a strong foundation for growth, and I am incredibly grateful for our talented global team and the opportunity to continue transforming the lives of millions of patients ...

The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.

A look back at the Office of Technology Assessment, the Congressional think tank that detected lies and tested tech.

Clinical trials may have to be scrapped, research applications will be pushed back, and unpaid researchers will quickly leave ...